Ceftazidime-avibactam or best available therapy in patients with ceftazidime-resistant Enterobacteriaceae and Pseudomonas aeruginosa complicated urinary tract infections or complicated intra-abdominal infections (REPRISE): a randomised, pathogen-directed, phase 3 study

Yehuda Carmeli, J. Armstrong, Peter J. Laud, Paul Newell, Greg Stone, Angela Wardman, Leanne B. Gasink

The Lancet Infectious Diseases · 2016 · 399 citations · 11 references

Concepts

References

11